MILESTONE SCIENTIFIC INC (MLSS)
US59935P2092 - Common Stock
We assign a fundamental rating of 3 out of 10 to MLSS. MLSS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. MLSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MLSS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MLSS had negative earnings in the past year.
MLSS had a negative operating cash flow in the past year.
MLSS had negative earnings in each of the past 5 years.
In the past 5 years MLSS always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of MLSS (-38.53%) is worse than 60.85% of its industry peers.
MLSS has a Return On Equity (-58.16%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -38.53% | ||
| ROE | -58.16% | ||
| ROIC | N/A |
ROA(3y)-52.98%
ROA(5y)-62.22%
ROE(3y)-71.09%
ROE(5y)-140.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of MLSS (72.39%) is better than 82.01% of its industry peers.
MLSS's Gross Margin has improved in the last couple of years.
MLSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y8.46%
2. Health
2.1 Basic Checks
MLSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MLSS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MLSS has more shares outstanding
The debt/assets ratio for MLSS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -3.24, we must say that MLSS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -3.24, MLSS is not doing good in the industry: 67.72% of the companies in the same industry are doing better.
MLSS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.24 |
ROIC/WACCN/A
WACC8.69%
2.3 Liquidity
A Current Ratio of 3.00 indicates that MLSS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.00, MLSS is in line with its industry, outperforming 50.79% of the companies in the same industry.
A Quick Ratio of 1.81 indicates that MLSS should not have too much problems paying its short term obligations.
The Quick ratio of MLSS (1.81) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3 | ||
| Quick Ratio | 1.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 44.11% over the past year.
MLSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.51%.
The Revenue has been growing slightly by 0.43% on average over the past years.
EPS 1Y (TTM)44.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-15.51%
Revenue growth 3Y21.79%
Revenue growth 5Y0.43%
Sales Q2Q%-36.3%
3.2 Future
The Earnings Per Share is expected to grow by 27.48% on average over the next years. This is a very strong growth
MLSS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.89% yearly.
EPS Next Y50%
EPS Next 2Y27.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.71%
Revenue Next 2Y5.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MLSS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MLSS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MLSS's earnings are expected to grow with 27.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MLSS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MILESTONE SCIENTIFIC INC
NYSEARCA:MLSS (9/6/2024, 8:04:00 PM)
1.03
+0.01 (+0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap79.55M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -38.53% | ||
| ROE | -58.16% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.39% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3 | ||
| Quick Ratio | 1.81 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)44.11%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y50%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.51%
Revenue growth 3Y21.79%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y